You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lipoprotein (a) Lp(a)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphedema Trial in Nice (lipoprotein (a))

Not yet recruiting
  • Lymphedema
  • lipoprotein (a)
  • Nice, Centre Antoine Lacassagne, France
    CAUSERET Marion
Jul 19, 2023

Lipoprotein(a) and Endogenous Fibrinolysis in Atherosclerotic

Recruiting
  • Atherosclerosis
  • Aortic Valve Disease
  • Thrombotic assessment
  • Measurement of Lp(a)
  • Stevenage, United Kingdom
    East and North Herts NHS Trust
Nov 6, 2023

Aortic Stenosis Trial (Pelacarsen (TQJ230) 80mg, Matching )

Not yet recruiting
  • Aortic Stenosis
  • Pelacarsen (TQJ230) 80mg
  • Matching placebo
  • (no location specified)
Dec 2, 2022

Cholesterol; Metabolic Disorder, Lipoproteinemia Trial in Nantes (infusion of tracer [5,5,5-2H3] -L-leucine)

Completed
  • Cholesterol; Metabolic Disorder
  • Lipoproteinemia
  • infusion of tracer [5,5,5-2H3] -L-leucine
  • Nantes, France
    Nantes University Hospital
Feb 22, 2022

Lp(a) With CCTA Assessed Parameters and Clinical Outcomes

Recruiting
  • Coronary Artery Disease
  • Coronary CTA
  • Shanghai, China
    Shanghai Zhongshan Hospital
Apr 4, 2022

Hyperlipidemias, Dyslipidemias, Elevated Lp(a) Trial in Worldwide (SLN360, Placebo)

Recruiting
  • Hyperlipidemias
  • +2 more
  • Jacksonville, Florida
  • +6 more
Mar 18, 2022

Lipoprotein Disorder Trial in Worldwide (LY3819469, Placebo)

Recruiting
  • Lipoprotein Disorder
  • Mesa, Arizona
  • +81 more
Jan 18, 2023

Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent Trial in Beijing (24 Months DAPT, 12 Months DAPT)

Not yet recruiting
  • Elevated Lipoprotein(a) Level
  • +3 more
  • 24 Months DAPT
  • 12 Months DAPT
  • Beijing, Beijing, China
    Fuwai Hospital, National Center for Cardiovascular Diseases, Chi
Aug 26, 2023

Acute Coronary Syndrome, Lipoprotein Disorder, Acute Myocardial Infarction Trial in Caserta

Recruiting
  • Acute Coronary Syndrome
  • +3 more
    • Caserta, Italy
      AORN S. Anna e S. Sebastiano
    Aug 9, 2022

    Cardiovascular Disease Trial in Saint-Denis (blood lipoprotein (a) test)

    Recruiting
    • Cardiovascular Disease
    • blood lipoprotein (a) test
    • Saint-Denis, France
      Centre Hospitalier Universitaire de la Réunion
    Aug 29, 2022

    Primary Hypercholesterolemia or Mixed Dyslipidemia Trial (Inclisiran, Matching Placebo for Inclisiran)

    Not yet recruiting
    • Primary Hypercholesterolemia or Mixed Dyslipidemia
    • (no location specified)
    May 24, 2023

    Elevated Serum Lipoprotein(a) Trial in Hong Kong (Olpasiran)

    Completed
    • Elevated Serum Lipoprotein(a)
    • Hong Kong, HK, Hong Kong
      Queen Mary Hospital
    Mar 30, 2022

    Thrombogenicity of Lipoprotein A: Laboratory Study Defining

    Not yet recruiting
    • Cardiovascular Disease and Lipid Disorders
    • Cardiac Disease
    • Non-interventional
    • Middlesbrough, Teesside, United Kingdom
      South Tees Hospitals NHS FT
    Apr 14, 2022

    Lipoprotein-associated Phospholipase A2 in Type 2 Diabetes

    Completed
    Has Results
    • Type2 Diabetes
      • (no location specified)
      Apr 12, 2022

      Hyperlipidemias, Dyslipidemias Trial (Obicetrapib)

      Not yet recruiting
      • Hyperlipidemias
      • Dyslipidemias
      • (no location specified)
      Aug 2, 2023

      Cardiovascular Diseases Trial in Shatin (TQJ230, Placebo)

      Active, not recruiting
      • Cardiovascular Diseases
      • Shatin, Hong Kong
        The Chinese University of Hong Kong
      Sep 16, 2022

      Cardiovascular Diseases, Atherosclerosis, Lipoprotein(a) Trial (SLN360, Placebo)

      Not yet recruiting
      • Cardiovascular Diseases
      • +2 more
      • (no location specified)
      Sep 12, 2022

      Relapsed or Refractory Lymphomas, Advanced Solid Tumor Trial in Los Alamitos (LP-284)

      Not yet recruiting
      • Relapsed or Refractory Lymphomas
      • Advanced Solid Tumor
      • Los Alamitos, California
        Cancer and Blood Specialty Clinic
      Nov 9, 2023

      Lipoprotein Disorder Trial in Worldwide (LY3473329, Placebo)

      Recruiting
      • Lipoprotein Disorder
      • Liverpool, New South Wales, Australia
      • +46 more
      Jan 18, 2023

      Hyperlipoproteinemia(a) Trial (Pelacarsen (TQJ230) 80 mg s.c., Corresponding Placebo)

      Not yet recruiting
      • Hyperlipoproteinemia(a)
      • Pelacarsen (TQJ230) 80 mg s.c.
      • Corresponding Placebo
      • (no location specified)
      Mar 22, 2022

      Hiv Trial (LP-98 injection)

      Not yet recruiting
      • Hiv
      • LP-98 injection
      • (no location specified)
      Jun 27, 2023

      Post-Lumbar Puncture Headache Trial in Houston (Modified Lumbar Puncture)

      Not yet recruiting
      • Post-Lumbar Puncture Headache
      • Modified Lumbar Puncture
      • Houston, Texas
        The University of Texas Health Science Center at Houston
      Oct 3, 2023

      Mantle Cell Lymphoma Trial in Hangzhou (LP-168 tablet)

      Recruiting
      • Mantle Cell Lymphoma
      • LP-168 tablet
      • Hangzhou, Zhejiang, China
        Second Affiliated Hospital, School of Medicine, Zhejiang Univers
      Jun 24, 2023

      To Reduce the LDL-C Level in Hypercholesteremia Adult Patients, Combination for Subgroup High LDL-c Patients With Other

      Not yet recruiting
      • To Reduce the LDL-C Level in Hypercholesteremia Adult Patients
      • Combination for Subgroup High LDL-c Patients With Other Comorbidities
      • RN0191 INJECTION
      • (no location specified)
      Jun 14, 2023

      Acute Coronary Syndrome, Lipoproteinemia, Inflammation Trial in Ljubljana (Pelacarsen (TQJ230), Placebo)

      Withdrawn
      • Acute Coronary Syndrome
      • +3 more
      • Pelacarsen (TQJ230)
      • Placebo
      • Ljubljana, Slovenia
        University Medical Centre Ljubljana-Department of Vascular disea
      Dec 10, 2021